Jennifer Herington

From left, Jennifer Herington, PhD, Jeff Reese, MD, Elaine Shelton, PhD, and Shajila Siricilla, PhD, are studying whether drugs given to premature infants in the NICU contribute to patent ductus arteriosus.
August 18, 2022

Study seeks to explore drug link to fetal vessel defect

Vanderbilt researchers have received a grant to study whether drugs given to premature infants in the neonatal intensive care unit (NICU) contribute to a potentially lethal condition called patent ductus arteriosus.

By Bill Snyder
February 9, 2016

Therapies to prevent preterm birth

Vanderbilt researchers have developed a high-throughput assay that will aid in identifying new compounds to treat preterm labor or postpartum bleeding.

By Leigh MacMillan